Bluefin Capital Management »

Takeda Pharmaceutical shares owned by Bluefin Capital Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Bluefin Capital Management from 13F filings

Historical chart of Bluefin Capital Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Bluefin Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Bluefin Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $202k 11k 18.52
2021-09-30 $208k 13k 16.35
2021-03-31 $1.1M 60k 18.27

More positions owned by Bluefin Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Coreweave Com Cl A (CRWV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Gold Tr Gold Shs (Principal) (GLD)
Alphabet Cap Stk Cl C (GOOG)
Lendingclub Issuance Tr Ser Com New Call Option
Alphabet Cap Stk Cl A (GOOGL)
Cogent Comm Holdings Com New (CCOI)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr Series Trust State Street Spd (CWB)
Bill Com Holdings Ord (BILL)
Ishares Msci Sth Kor Etf (EWY)
Wendy's/arby's Group (Principal) (WEN)
Energy Transfer Com Ut Ltd Ptn (ET)

View all positions for Bluefin Capital Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
FMR
Morgan Stanley
Adage Capital Partners GP
Goldman Sachs Group
Brandes Investment Partners
BlackRock
Arrowstreet Capital, Limited Partnership
Renaissance Technologies
UBS Group
D. E. Shaw & Co
Van Eck Associates Corp.
Citadel Advisors
First Trust Advisors
Northern Trust

View all funds holding Takeda Pharmaceutical